Advanced HCC: 2nd Line Treatment Selection And The Right Time To Switch COR2ED Medical Education podcast

Artwork

Science COR2ED Higher Education Medical Education Fitness Podcasting Education Medicine

Indhold leveret af COR2ED. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af COR2ED eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

COR2ED Medical Education « »
Advanced HCC: 2nd line treatment selection and the right time to switch

1y ago 29:25

Del

MP3•Episode hjem

Indhold leveret af COR2ED. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af COR2ED eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

COR2ED Medical Education: Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at UZ Leuven, Belgium, discuss the new era in treating patients with advanced HCC, focusing on treatment selection and the right time to switch to 2^nd line therapy.

In this podcast, the experts give an overview of the current 1^st and 2^nd line systemic treatment options and sequences for patients with advanced HCC by looking into the results from different clinical trials and current guidelines. They also shine a light on the differences in approved 2^nd line systemic therapies between Europe and USA.

The experts present their approach in making the decision to switch to 2^nd line therapy, thereby taking toxicity, liver function and disease progression into account. They also discuss the need for comparative effectiveness data to determine the optimal 2^nd line therapy.

… continue reading

89 episoder

#Science #COR2ED #Higher Education #Medical Education #Fitness #Podcasting Education #Medicine

Artwork

Advanced HCC: 2nd line treatment selection and the right time to switch

COR2ED Medical Education

published 1y ago

Del

MP3•Episode hjem

Indhold leveret af COR2ED. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af COR2ED eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

COR2ED Medical Education: Prof. Dr Amit Singal, Gastroenterologist and Hepatologist at UT Southwestern Medical Center, USA and Prof. Dr Jeroen Dekervel, GI Oncologist at UZ Leuven, Belgium, discuss the new era in treating patients with advanced HCC, focusing on treatment selection and the right time to switch to 2^nd line therapy.

In this podcast, the experts give an overview of the current 1^st and 2^nd line systemic treatment options and sequences for patients with advanced HCC by looking into the results from different clinical trials and current guidelines. They also shine a light on the differences in approved 2^nd line systemic therapies between Europe and USA.

The experts present their approach in making the decision to switch to 2^nd line therapy, thereby taking toxicity, liver function and disease progression into account. They also discuss the need for comparative effectiveness data to determine the optimal 2^nd line therapy.

… continue reading

89 episoder

#Science #COR2ED #Higher Education #Medical Education #Fitness #Podcasting Education #Medicine

すべてのエピソード

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner